MD1052G2 - Metodă de imunoterapie Cuşnir - Google Patents

Metodă de imunoterapie Cuşnir

Info

Publication number
MD1052G2
MD1052G2 MD98-0039A MD980039A MD1052G2 MD 1052 G2 MD1052 G2 MD 1052G2 MD 980039 A MD980039 A MD 980039A MD 1052 G2 MD1052 G2 MD 1052G2
Authority
MD
Moldova
Prior art keywords
stabilization
immunocompetent cells
immunotherapy method
kushnir
cultural medium
Prior art date
Application number
MD98-0039A
Other languages
English (en)
Russian (ru)
Inventor
Георге КУШНИР
Original Assignee
Георге КУШНИР
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Георге КУШНИР filed Critical Георге КУШНИР
Priority to MD98-0039A priority Critical patent/MD1052G2/ro
Publication of MD1052G2 publication Critical patent/MD1052G2/ro

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Invenþia se referã la medicinã, în special la imunologie ºi poate fi utilizatã în cadrul tratamentului afecþiunilor inflamatorii ºi distrofice ale þesuturilor moi, precum ºi a defectelor þesuturilor moi.Metoda de imunoterapie constã în prelevarea sângelui, separarea din el a celulelor imunocompetente, stabilizarea lor în mediu de culturã la temperatura de 37°C în decurs de 30 min...48 ore, suspensionarea în ser fiziologic steril ºi administrarea în microambianþa procesului patologic. Stabilizarea celulelor imunocompetente în mediul de culturã poate fi efectuatã în prezenþa preparatelor imunomodulatoare.Rezultatul tehnic constã în activizarea reacþiilor imune ºi a sintezei proteinelor, în inhibarea reacþiei inflamatoare, ceea ce condiþioneazã un efect rezolutiv ºi regenerativ.
MD98-0039A 1998-02-18 1998-02-18 Metodă de imunoterapie Cuşnir MD1052G2 (ro)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MD98-0039A MD1052G2 (ro) 1998-02-18 1998-02-18 Metodă de imunoterapie Cuşnir

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MD98-0039A MD1052G2 (ro) 1998-02-18 1998-02-18 Metodă de imunoterapie Cuşnir

Publications (1)

Publication Number Publication Date
MD1052G2 true MD1052G2 (ro) 1999-04-30

Family

ID=62129547

Family Applications (1)

Application Number Title Priority Date Filing Date
MD98-0039A MD1052G2 (ro) 1998-02-18 1998-02-18 Metodă de imunoterapie Cuşnir

Country Status (1)

Country Link
MD (1) MD1052G2 (ro)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD2259G2 (ro) * 2002-11-29 2004-03-31 КАМЫШ Елена Metodă de tratament al spondiloartralgiei autoimune la copii
MD2396G2 (ro) * 2003-11-13 2004-11-30 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Metodă de tratament al ulcerelor duodenale cronice şi recidivante postoperatorii
MD2784G2 (ro) * 2005-02-23 2006-03-31 Тудор АБАБИЙ Metodă de tratament al herniilor ventrale gigantice
MD1179Z (ro) * 2017-03-29 2018-03-31 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Metodă de tratament al ulcerelor trofice

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Журнал Гигиена, Эпидемиология, Микробиология и Иммунология, т. 30, № 3, 1986 (Прага, Н. Н. Клемпарская, Г. А. Шальнова, А. М. Уланова и др. "Иммуномодулирующее влияние аутогемотерапии", с. 343-349). *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD2259G2 (ro) * 2002-11-29 2004-03-31 КАМЫШ Елена Metodă de tratament al spondiloartralgiei autoimune la copii
MD2396G2 (ro) * 2003-11-13 2004-11-30 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Metodă de tratament al ulcerelor duodenale cronice şi recidivante postoperatorii
MD2784G2 (ro) * 2005-02-23 2006-03-31 Тудор АБАБИЙ Metodă de tratament al herniilor ventrale gigantice
MD1179Z (ro) * 2017-03-29 2018-03-31 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Metodă de tratament al ulcerelor trofice

Similar Documents

Publication Publication Date Title
Peters et al. Preparation of immunotherapeutic autologous tumor cell vaccines from solid tumors
Clayberger et al. Immunoregulatory activities of autoreactive T cells: an IA-specific T cell clone mediates both help and suppression of antibody responses.
DK1225870T3 (da) Sammensætning og fremgangsmåde til cancerantigenimmunterapi
Michaëlssony et al. Macrophages, but not dendritic cells, present collagen to T cells
CA2387542A1 (en) Supernatant from mesenchymal stem cells for prevention and treatment of immune responses in transplantation
EE05025B1 (et) Fumaarhappe derivaadid kasutamiseks transplantaadivastase reaktsiooni raviks
JPS61227526A (ja) 新規なコロニー刺激因子
PT633930E (pt) Geracao in vitro de celulas dendriticas humanas e utilizacoes destas
EP0690125A3 (en) Process for induction culture of cytotoxict lymphocytes having killing activity against tumor cells
MD1052G2 (ro) Metodă de imunoterapie Cuşnir
IL113024A (en) Quinazolinyl-amino derivatives having alpha-antagonist activity their preparation and pharmaceutical compositions comprising them
Kogo et al. Suppression of murine tumour growth through CD 8+ cytotoxic T lymphocytes via activated DEC‐205+ dendritic cells by sequential administration of α‐galactosylceramide in vivo
Rouse et al. In vivo activity of in vitro immunized lymphocytes: I. Tumor allograft rejection mediated by in vitro activated mouse thymocytes
Bukovský et al. Allosensitization in tumor therapy and prophylaxis, and in female contraception—A prospect for clinical use
Kedar et al. Studies on the Induction and Expression of T Cell-Mediated Immunity: IV. Non-Overlapping Populations of Alloimmune Cytotoxic Lymphocytes with Specificity for Tumor-Associated Antigens and Transplantation Antigens
US5861158A (en) Method and composition for transfer of active tumor-specific immunization from an immunized allogeneic bone marrow donor
Cavazza et al. Hydrolysis of the tumor-associated antigen epitope gp100280–288 by membrane-associated and soluble enzymes expressed by immature and mature dendritic cells
Sensi et al. Original H‐2d and alien H‐2k‐like antigens of a BALB/c fibrosarcoma as defined by in vitro and in vivo studies of cell‐mediated immunity
Jacobs et al. Lymphokine activateed killer (LAK) cell-mediated lysis of murine glioma: trypsinchymotrypsin-sensitive glioma protein is responsible for tumor-selective recognition by LAK cells
Hakim Isolation of a protease from the cell-free medium of in vitro cultured mammary carcinoma
DE69420574D1 (de) Derivate von therapeutisch in der blutgerinnungskaskade wirksamen peptiden, verfahren zur herstellung und sie enthaltende pharmazeutische zubereitungen
Kedar et al. In vitro induction of cell-mediated immunity to murine leukemia cells. VII. Methods for augmenting the induction and expression of cytotoxic response in vitro to syngeneic tumors
MD1119G2 (ro) Metodă de tratament al afecţiunilor inflamatorii ale organelor genitale feminine
Kitagawa et al. Analyses of origin of synovial cells and repairing mechanisms of arthritis by allogeneic bone marrow transplantation
Darnule et al. Antiserum to surface antigens as a marker for cultured rat lung endothelial cells (1)

Legal Events

Date Code Title Description
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees